Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Gold IRA Companies
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Gold IRA Review
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
CYTK
Stock Latest News
Ratings
Cytokinetics Maintained at Buy on Competitive Validation and Differentiation; $99 Price Target Reaffirmed
2m ago
CYTK
Premium
Ratings
Analyst Reiterates Buy on Cytokinetics, Citing Aficamten’s Best-in-Class Profile and Safety Edge, Keeps $103 Price Target Unchanged
3m ago
CYTK
Premium
Ratings
Cytokinetics: Competitive Overhang Eases After EDG-7500 Data, Analyst Reiterates Buy and $102 Price Target
15h ago
CYTK
Premium
The Fly
Cytokinetics launches Myqorzo in Germany
16d ago
CYTK
Premium
Company Announcements
Cytokinetics Shareholders Reinforce Board and Governance Frameworks
21d ago
8K
CYTK
Premium
Market News
Citi Names 2 Biotech Stocks ‘Top Picks’ for 2026
24d ago
CYTK
IONS
Premium
Company Announcements
Cytokinetics Earnings Call Signals Transformational Launch
28d ago
CYTK
Premium
The Fly
StubHub, Jazz Pharmaceuticals upgraded: Wall Street’s top analyst calls
29d ago
AMT
BAP
Premium
The Fly
Cytokinetics initiated with a Buy, named a top pick at Citi
30d ago
CYTK
Premium
The Fly
Cytokinetics price target raised to $97 from $92 at JPMorgan
1M ago
CYTK
Premium
The Fly
Cytokinetics announces new data related to Myqorzo at ESC Heart Failure 2026
1M ago
CYTK
Premium
The Fly
Cytokinetics price target raised to $140 from $136 at H.C. Wainwright
1M ago
CYTK
Premium
Company Announcements
Cytokinetics Raises $760 Million in Stock Offering
1M ago
8K
CYTK
Premium
The Fly
Cytokinetics price target raised to $105 from $95 at Wells Fargo
1M ago
CYTK
Premium
The Fly
Cytokinetics 9.8M share Secondary priced at $71.00
1M ago
CYTK
Premium
The Fly
Cytokinetics price target raised to $108 from $98 at Stifel
1M ago
CYTK
Premium
The Fly
Cytokinetics price target raised to $119 from $101 at RBC Capital
1M ago
CYTK
Premium
The Fly
Cytokinetics price target raised to $103 from $90 at Morgan Stanley
1M ago
CYTK
Premium
Ratings
Maxwell Skor Lifts Cytokinetics Price Target to $103 and Reiterates Buy on Strong Phase 3 ACACIA-HCM Results for Aficamten
1M ago
CYTK
Premium
Company Announcements
Cytokinetics Earnings Call Highlights Launch, Trial Wins
1M ago
CYTK
Premium
Company Announcements
Cytokinetics Highlights MYQORZO Progress and Cardiology Pipeline
1M ago
8K
CYTK
Premium
Ratings
Analyst Maintains Buy Rating and $136 Price Target on Aficamten Following Strong Phase 3 ACACIA-HCM Results
1M ago
CYTK
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
